Japanese pharma group takes on new jab that makes immune system attack dangerous protein build-up in brain
Drugmaker follows Eli Lilly in cutting out middlemen and selling directly to patients
Machine intelligence is not yet a substitute for the experimentation that underpins understanding of a disease
Agreement worth up to $1.2bn includes plan for combined flu and Covid shots
Too many are leaving the profession in despair at stagnant pay and poor working conditions
Experts are divided on whether the shift towards private care is good or bad for the public health service in the long term
Increases in doctors’ bills, insurance and ‘lifestyle diseases’ are expected to boost hospital revenues
AlphaFold 3 aims to reveal biological secrets and boost drug search efforts
Anglo-Swedish drugmaker says availability of newer vaccines hit demand for jab
UK drug group says for third time this year that auditors have been unable to finish checking its accounts
Food and Drug Administration poised to call for outside assessment of Lykos PTSD therapy in test for psychedelics sector
Weight-loss treatments are not the only source of excitement in the pharmaceutical research world
Novo Nordisk, Bill & Melinda Gates Foundation and Wellcome focus on interlinked issues
Experts warn better data is required to drive policy as debilitating condition reduces workforce
Employees are being offered the ‘party drug’ through company health schemes as psychedelic-assisted therapy grows in popularity
Boom in healthcare borrowing prompts warnings from doctors and campaigners
An FT special report looking at changes in healthcare, treatments and illness itself
Business launched just after cancer diagnosis
For stretched public health budgets, high-tech treatments are hard to afford but some pre-emptive measures can prove good value
Caseloads of cancer and other illnesses of ageing are forecast to rise steeply in lower income countries
Danish group beats expectations with first-quarter sales up 24% and raises annual forecast on high demand
Wellcome’s John-Arne Røttingen says divisions risk harming action on pandemic responses and ‘superbugs’
Dentists says ‘punitive targets’ under NHS contract system are stifling delivery across the country
The UK is a world leader in finding new treatments to tackle diseases
The retailer is right to cut losses and shut its healthcare centres and telehealth operation
International Edition